Page 103 - 《中国药房》2025年9期
P. 103

·药学服务·


          我国医疗机构药学监护开展现状调查
                                                                   Δ

                          2, 3
                                    1
                                                    3
                                            1
                                                            3, 4
          郑婷婷 ,张宇晴 ,刘思彤 ,张 威 ,陆 进 ,沈群红 ,甄健存 (1.首都医科大学附属北京积水潭医院药
                 1*
                                                                      1, 3 #
          学部,北京 100035;2.北京大学药学院,北京 100191;3.中国医院协会药事专业委员会,北京 100035;4.清
          华大学公共管理学院卫生与发展研究中心,北京 100084)
          中图分类号  R95      文献标志码  A      文章编号  1001-0408(2025)09-1117-06
          DOI  10.6039/j.issn.1001-0408.2025.09.17

          摘  要  目的  调查我国医疗机构药学监护开展现状,为药学监护持续发展提供经验和建议。方法  采用问卷调查法,于2023年3
          月调研31个省(自治区、直辖市)医疗机构药学监护的开展情况,对结果进行描述性分析,并对药学监护开展的影响因素进行二元
          Logistic回归分析。结果  共发放问卷1 368份,收回有效问卷1 304份,问卷有效回收率为95.32%。有671家(51.46%)医疗机构开
          展了药学监护,其中三级、二级、一级及其他医疗机构药学监护开展率分别为74.79%、27.97%、7.35%。平均年药学监护服务患者
          量为2 638.96人次,平均每家医疗机构有8.33名药师开展药学监护,开展药学监护药师中有93.68%是临床药师。药学监护服务覆
          盖的主要科室包括呼吸与危重症医学科、心内科、重症医学科、内分泌科、肿瘤科、消化内科、妇产科等。对药学监护服务有额外补
          偿的医疗机构为48家(7.15%)。开展药学监护的主要经验是重视人才培养和重视学科建设,面临的主要困难是人员短缺、符合要
          求的人才严重不足和补偿水平低、开展的积极性不高。医疗机构等级、医疗机构从事临床药学工作的药师数量、医疗机构有临床
          药师资质的药师数量以及医疗机构药学部信息化程度是开展药学监护的主要影响因素(P<0.05)。结论  近年来我国医疗机构药
          学监护取得了一定进展,但一、二级及其他医疗机构药学监护开展率仍有较大的提升空间。后续仍需进一步推进药学监护开展、
          加强人才培养、重视药学监护价值体现,进而促进药学监护可持续、高质量发展。
          关键词  药学监护;现状;问卷调查;影响因素

          Investigation on the current status of pharmaceutical care in medical institutions in China

                                         2, 3
                                                      1
                         1
          ZHENG Tingting ,ZHANG Yuqing ,LIU Sitong ,ZHANG Wei ,LU Jin ,SHEN Qunhong ,ZHEN Jiancun          1, 3
                                                                   1
                                                                           3
                                                                                           3, 4
         (1.  Dept.  of  Pharmacy,  Beijing  Jishuitan  Hospital,  Capital  Medical  University,  Beijing  100035,  China;
          2.  School  of  Pharmaceutical  Sciences,  Peking  University,  Beijing  100191,China;3.  Pharmaceutical  Specialized
          Committee,Chinese  Hospital Association,  Beijing  100035,China;4.  Health  and  Development  Institute,  School
          of Public Policy & Management, Tsinghua University,Beijing 100084,China)
          ABSTRACT   OBJECTIVE  To investigate the current status of pharmaceutical care in medical institutions in China, and provide
          experience and suggestions for better development of pharmaceutical care. METHODS Questionnaire survey was used to investigate
          the development of pharmaceutical care in medical institutions in 31 provinces (autonomous regions and municipalities directly) in
          March 2023, and descriptive analysis and binary logistic regression analysis on the influencing factors of pharmaceutical care were
          conducted.  RESULTS  A  total  of  1  368  questionnaires  were  sent  out,  and  1  304  valid  questionnaires  were  collected  with  the
          effective  recovery  rate  of  95.32%.  Pharmaceutical  care  was  carried  out  in  671  medical  institutions (51.46%),  and  the  rates  of
          pharmaceutical  care  in  tertiary,  secondary,  primary  and  other  medical  institutions  were  74.79%,  27.97%  and  7.35%,  respectively.
          The  average  number  of  patients  receiving  pharmaceutical  care  was  2  638.96  per  year,  and  there  were  8.33  pharmacists  in  each
          medical institution to carry out pharmaceutical care, among which 93.68% were clinical pharmacists. The main departments covered
          by  pharmaceutical  care  services  included  respiratory  and  critical  care  medicine,  cardiology,  intensive  care  unit,  endocrinology,
                                                             oncology,  gastroenterology,  obstetrics  and  gynecology  and
             Δ 基金项目 北京市属医院科研培育计划项目(No.PG2023009)             other  departments.  There  were  only  48  medical  institutions
             *第一作者 主管药师,硕士。研究方向:临床药学、药事管理。
                                                            (7.15%)  with  additional  compensation  for  pharmaceutical  care
          E-mail:sunny_lights@163.com
             # 通信作者 主任药师,硕士。研究方向:医院药学、临床药学、药                 services.  The  main  experiences  of  developing  pharmaceutical
          事管理。E-mail:zhenjiancun@163.com                     care  were  to  pay  attention  to  talent  cultivation  and  discipline


          中国药房  2025年第36卷第9期                                                China Pharmacy  2025 Vol. 36  No. 9    · 1117 ·
   98   99   100   101   102   103   104   105   106   107   108